Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 8;8(34):55950-55957.
doi: 10.18632/oncotarget.19116. eCollection 2017 Aug 22.

PKCθ utility in diagnosing c-KIT/DOG-1 double negative gastrointestinal stromal tumors

Attila Kövecsi #  1   2 , Ioan Jung #  1 , Zoltan Szentirmay  3 , Tivadar Bara  4 , Tivadar Bara Jr  4 , Daniel Popa  4 , Simona Gurzu  1   2   5
Affiliations

PKCθ utility in diagnosing c-KIT/DOG-1 double negative gastrointestinal stromal tumors

Attila Kövecsi et al. Oncotarget. .

Abstract

Background: The aim of this study was to evaluate the diagnosis value of an immunohistochemical (IHC) panel of three antibodies for the diagnosis of gastrointestinal stromal tumors (GISTs).

Material and methods: In 80 consecutive GISTs without lymph node metastases, the IHC examinations were performed using the antibodies CD117 (c-KIT), DOG-1 and c-theta (PKCθ) protein. The diagnostic value of PKCθ in c-KIT/DOG-1 negative GISTs has been explored in fewer than 10 Medline-indexed papers.

Results: The c-KIT, PKCθ and DOG-1 positivity was noted in 92.50% (n = 74), 90% (n = 72) and 76.25% (n = 61) of the cases, respectively. All of the C-KIT negative cases (n = 6) were also DOG-1 negative but displayed PKCθ positivity. All of the DOG-1 positive cases (n = 61) also expressed c-KIT. No correlation between the examined markers and clinicopathological parameters was noted.

Conclusions: The PKCθ sensitivity is similar to c-KIT and superior to DOG-1 sensitivity. All of the c-KIT/DOG-1 negative GISTs seem to express PKCθ. For a proper diagnosis of GIST, the c-KIT/DOG-1/PKCθ panel should be used, with possible therapeutic but not prognostic value.

Keywords: CD117; GIST; Pathology Section; c-theta; diagnosis; protein kinase.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTERESTS No conflict of interests are declared.

Figures

Figure 1
Figure 1. Correlation between c-KIT, DOG-1 and PKCθ expression revealed by Venn-diagram
Figure 2
Figure 2
Negative immunoexpression of c-KIT (A), DOG-1 (B) and PKCθ (C) in gastrointestinal stromal tumors.
Figure 3
Figure 3
Positive immunoexpression of c-KIT (A), DOG-1 (B) and PKCθ (C) in gastrointestinal stromal tumors.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Rubin BP, Heinrich MC, Corless CL. Gastrointestinal stromal tumour. Lancet. 2007;369:1731–1741. - PubMed
    1. Soreide K, Sandvik OM, Soreide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39–46. - PubMed
    1. Klieser E, Pichelstorfer M, Weyland D, Kemmerling R, Swierczynski S, Dinnewitzer A, Jager T, Kiesslich T, Neureiter D, Illig R. Back to the start: evaluation of prognostic markers in gastrointestinal stromal tumors. Mol Clin Oncol. 2016;4:763–773. - PMC - PubMed
    1. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O’Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459–465. - PubMed
    1. Nishida T, Blay JY, Hirota S, Kitagawa Y, Kang YK. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Gastric Cancer. 2016;19:3–14. - PMC - PubMed

LinkOut - more resources